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ABSTRACT
Motivation: Microarray experiments generate large
datasets with expression values for thousands of genes
but not more than a few dozens of samples. Accurate
supervised classification of tissue samples in such
high-dimensional problems is difficult but often crucial for
successful diagnosis and treatment. A promising way to
meet this challenge is by using boosting in conjunction
with decision trees.
Results: We demonstrate that the generic boosting al-
gorithm needs some modification to become an accurate
classifier in the context of gene expression data. In par-
ticular, we present a feature preselection method, a more
robust boosting procedure and a new approach for multi-
categorical problems. This allows for slight to drastic in-
crease in performance and yields competitive results on
several publicly available datasets.
Availability: Software for the modified boosting algorithms
as well as for decision trees is available for free in R at
http://stat.ethz.ch/∼dettling/boosting.html.
Contact: dettling@stat.math.ethz.ch
1 INTRODUCTION
The recently developed microarray technology allows for
measuring expression levels of thousands of genes simul-
taneously. We focus on the case where the experiments
monitor gene expression values of different individuals or
tissue samples, and where each experiment is equipped
with an additional categorical outcome variable describ-
ing a cancer (pheno)type. In such a supervised setting, our
goal is to predict the unknown class label of a new individ-
ual on the basis of its gene expression profile, since pre-
cise diagnosis of cancer type is often crucial for successful
treatment. Given the availability of efficient classification
techniques, bio-molecular information could become as,
or even more important than traditional clinical factors.
Classification of different phenotypes, predominantly
cancer types, using microarray gene expression data has
been considered by Golub et al. (1999), Alon et al.
(1999), Ben-Dor et al. (2000), Furey et al. (2000), Slonim
∗To whom correspondence should be addressed.
et al. (2000), Dudoit et al. (2002), West et al. (2001)
and Zhang et al. (2001), among others. The methods
used in these studies range from classical discriminant
analysis over Bayesian approaches and clustering methods
to flexible tools from machine learning such as bagging,
boosting and support vector machines. Explicitly, boosting
decision trees has been applied for the classification of
gene expression data in Ben-Dor et al. (2000) and Dudoit
et al. (2002). Both studies compare the original AdaBoost
algorithm that was proposed by Freund and Schapire
(1997) against other classifiers, and both recognize that
boosting does not yield very impressive results.
In this paper we demonstrate that the performance of
boosting for classification of gene expression data can
often be drastically improved by modifying the algorithm
as follows: First, we perform feature preselection with the
nonparametric scoring method of Park et al. (2001). Then,
we apply the LogitBoost procedure introduced by Fried-
man et al. (2000) instead of the AdaBoost procedure. The
former was found to have a slight edge over AdaBoost
in a variety of more traditional classification problems
(Friedman et al., 2000),and it usually performs better on
noisy data or when there are misspecifications or inhomo-
geneities of the class labels in the training data, which is
frequently the case with microarray gene expression data.
Finally, if discrimination has to be done for more than two
tumor types, we reduce multiclass to multiple binary prob-
lems so that different gene subsets and different model
complexity for discriminating different tumor types are
allowed. This multiclass approach turns out to be much
more accurate than the direct multiclass LogitBoost algo-
rithm of Friedman et al. (2000). On six publicly available
datasets and with a simulation study we show that the sum
of these modifications leads to a classification procedure
which performs very competitively, does not require
sophisticated fine tuning and is fairly easy to implement.
2 METHODS
2.1 The stochastic framework
We assume that we are given n training data pairs
(x1, y1), . . . , (xn, yn),
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with xi ∈ Rp and yi ∈ {0, . . . , J − 1}, which are
independent and identically distributed realizations of
a random vector (X, Y ). The interpretation is that the
feature or input vector X models the p-dimensional gene
expression profile and the response or output variable
Y denotes the class label. Today, the sample size n is
typically in the range of 20 to 80 and the number of
monitored genes p varies between 2000 and 20 000.
In the standard classification problem, the goal is to
predict the class label Y , based on the expression vector
X . This amounts to construct a classifier function
C : X → C(X) ∈ {0, . . . , J − 1},
which can subsequently be used to predict the unknown
class label of a new tissue sample based on its expression
vector. The optimal classifier is such that the misclassifi-
cation risk
P
[C(X) = Y ] is minimal. (1)
Note that this quantity is most often different from zero.
The solution of Equation (1) requires knowledge of the
true, but generally inaccessible conditional probability
distribution P[Y = j |X ] and is called Bayes classifier,
CBayes(X) = argmax j∈{0,...,J−1}P[Y = j |X ]. (2)
In practice, it can be constructed via estimated conditional
probabilities P̂[Y = j |X ]. This is a classical task for
p  n, but expression data with many more features than
samples (p 	 n) create a new challenge. A promising way
to find a good discriminative model is by using boosting
in conjunction with decision trees.
2.2 Binary classification of gene expression data
We focus first on binary problems with response Y ∈
{0, 1}. The best way to handle multi-categorical problems
is explained later in Section 2.3.
2.2.1 Feature preselection The intrinsic problem with
classification from microarray data is that sample size n
is much smaller than the dimensionality of the feature
space, i.e. the number of genes p. Many genes are non-
differentially expressed across the samples and irrelevant
for phenotype discrimination. Dimensionality reduction of
the feature space has been performed by many authors, see
for example Golub et al. (1999), Ben-Dor et al. (2000) and
Dudoit et al. (2002), among others. It drastically eases the
computational burden and for many problems improves
class prediction due to the reduced amount of noise.
Our feature selection is based on scoring each individual
gene g, with g ∈ {1, . . . , p}, according to its strength
for phenotype discrimination. We use a nonparametric
method that is based on ranks and was presented by Park
et al. (2001). It is in fact equivalent to the test statistic of
Wilcoxon’s two sample test,
Score(g) = s(g) =
∑
i∈N0
∑
j∈N1
1[x (g)j −x (g)i ≤0]
,
where x (g)i is the expression value of gene g for individual
i andNm represents the set of the nm indices ∈ {1, . . . , n}
having response in m ∈ {0, 1}. The score function can
be interpreted as counting for each individual having re-
sponse value zero, the number of instances with response
one that have smaller expression values, and summing up
these quantities. Viewing it as Wilcoxon’s test statistic, it
allows ordering of the genes according to their potential
significance. It captures to what extent a gene g discrim-
inates the response categories and it is easy to notice that
both values near the minimum score zero and the maxi-
mum score n0n1 indicate a differentially expressed, infor-
mative gene. The quality measure
q(g) = max(s(g), n0n1 − s(g))
thus gives the highest values to those genes whose
expression levels have the best strength for phenotype
discrimination. We then simply take the p˜ ≤ p genes
with the highest values of q(g) as our top features and
restrict the boosting classifier to work with this subset.
The number of predictor variables is a tuning parameter
whose optimal value varied across different datasets. A
formal choice of p˜ is possible via cross validation on the
training data or by determining the correct null distribution
by bootstrap methods and a decision on significance
levels as in Park et al. (2001). Many more variable
selection criteria for gene expression data have been
proposed in the literature. We think that our approach
based on Wilcoxon’s test statistic is more suitable in
the context of gene expression data than the t-statistic
used in Dudoit et al. (2002), or the TNoM score (Ben-
Dor et al., 2000) which corresponds to counting the
number of errors made by the best stump, a decision
tree with two terminal nodes. The situation is similar to
the trade-off between t-, Wilcoxon- and sign-test. It is
known from robustness theory that the t-test is highly
sensitive to outliers and (even small) deviations from the
normal distribution, whereas the sign-test (TNoM score)
wastes useful information about the magnitude of gene
expression levels. A good compromise is the Wilcoxon-
test which has nearly optimal power properties over a large
class of data-generating distributions, see Hampel et al.
(1986).
2.2.2 Binary LogitBoost with decision trees Boosting,
first introduced by Freund and Schapire (1996) has
been found to be a powerful classification technique
with remarkable success on a wide variety of problems,
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especially in higher dimensions. It aims at producing an
accurate combined classifier from a sequence of weak (or
base) classifiers, which are fitted to iteratively reweighted
versions of the data. In each boosting iteration m, with
m ∈ {1, 2, . . . , M}, the observations that have been
misclassified at the previous step have their weights
increased, whereas the weights are decreased for those
that were classified correctly. The mth weak classifier
f (m) is thus forced to focus more on individuals that have
been difficult to classify correctly at earlier iterations. The
combined classifier is equivalent to a weighted majority
vote of the weak classifiers for shifted labels ∈ {−1, 1},
C(M)(X) = sign
(
M∑
m=1
αm f (m)(X)
)
.
Three elements need to be chosen: (i) the type of weak
learners f (m); (ii) the reweighting of the data and the
aggregation weights αm ; and (iii) the number of boosting
iterations M . Regarding issue (i), we exclusively focus
on decision trees, see Breiman et al. (1984). These are
the most popular learners in conjunction with boosting.
In fact, we even further restrict here to stumps, which
are trees with two terminal nodes only, since in the
context of gene expression data, this always yielded
better or equal performance than boosting larger trees.
Concerning issue (ii), the reweighting of the data and
the choice of aggregation weights can be coherently
motivated by the principle of functional gradient descent
(Breiman, 1999; Friedman et al., 2000), from which
several versions of boosting for classification emerge. We
build here on the LogitBoost introduced by Friedman et
al. (2000): it relies on the binomial log-likelihood as a loss
function, which is a more natural criterion in classification
than the exponential criterion underlying the AdaBoost
algorithm. Since the former increases linearly instead of
exponentially for strongly negative margins (see Hastie et
al., 2001), it is more robust in noisy problems where the
misclassification risk of Equation (1) is substantial, and
also in situations where mislabeled training data points or
inhomogeneities in the training samples are present, all of
which can be the case with gene expression data. Finally
regarding (iii), the choice of the stopping parameter is
often neglected and the boosting process is stopped at a
usually large, but arbitrarily fixed number of iterations.
Alternatively, we consider an empirical approach for the
choice of M in the next section. The binary LogitBoost
with decision stumps as weak learner works then as
follows:
Step 1: Initialization
Start with an initial committee function F (0)(x) ≡ 0 and
initial probabilities p(0)(x) ≡ 1/2; p(x) is an abbreviation
for P̂[Y = 1|X = x].
Step 2: LogitBoost iterations
For m = 1, 2, . . . , M repeat:
A. Fitting the weak learner
(i) Compute working response and weights for all
i = 1, . . . , n
w
(m)
i = p(m−1)(xi ) ·
(
1 − p(m−1)(xi )
)
,
z(m)i =
yi − p(m−1)(xi )
w
(m)
i
.
(ii) Fit a regression stump f (m) by weighted least
squares
f (m) = argmin f
n∑
i=1
w
(m)
i (z
(m)
i − f (xi ))2.
B. Updating and classifier output
F (m)(xi ) = F (m−1)(xi ) + 12 f
(m)(xi ).
C(m)(xi ) = sign
(
F (m)(xi )
)
,
p(m)(xi ) =
(
1 + exp
(
−2 · F (m)(xi )
))−1
.
To increase understanding of the LogitBoost algorithm,
we point out that each committee function F (m)(x) is an
estimate of half of the log-odds ratio
F(x) = 1
2
log
(
p(x)
1 − p(x)
)
.
LogitBoost thus fits an additive logistic regression model
by stagewise optimization of the binomial log-likelihood.
More details can be found in Friedman et al. (2000),
A very useful property of our classification method is
that it directly yields probability estimates P̂[Y = j |X =
x]. This is crucial for constructing classifiers respecting
non-equal misclassification costs. Moreover, it allows to
build classifiers which have the option to assign the label
‘no class’ (or ‘doubt’) for certain regions in the space of
gene expression vectors x , see for example Ripley (1996).
An important advantage of LogitBoost compared to
methods like neural nets or support vector machines is
that it works well without fine tuning and no sophis-
ticated nonlinear optimization is necessary. Provided
that a decision tree algorithm is available, e.g. versions
of CART (Breiman et al., 1984) or C4.5 (Quinlan,
1993), LogitBoost with trees can be implemented very
easily. Software for decision trees is widely available:
for example for free as an R-Package called rpart, at
http://www.stat.math.ethz.ch/CRAN.
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2.2.3 Choice of the stopping parameter The stopping
parameter M is often simply fixed at a large number in
the range of dozens or hundreds. This, because boosting
is generally quite resistant against overfitting so that the
choice of M is typically not very critical, see also Figure
1. An alternative is to use an empirical approach for
estimation of M by leave-one-out cross validation on the
training data. The idea is to compute the binomial log-
likelihood
(m) =
n∑
i=1
log
(
p̂(m)(xi )
)
· 1[Yi=1] +
+ log
(
1 − p̂(m)(xi )
)
· 1[Yi=0], (3)
for each boosting iteration m across the samples and
to choose the stopping parameter as the m for which
(m) is maximal. We observed that (m) usually peaks
somewhere between 10 and 100 boosting iterations.
However empirically, we could not exploit significant
advantages of estimated stopping parameters against a
choice of M = 100 in the gene expression data we
considered.
2.3 Reducing multiclass to binary
Here we explain how multi-response problems (J >
2) can be handled in conjunction with boosting. We
recommend to compare each response class separately
against all other classes. This one-against-all approach
for reduction to J binary problems is very popular in the
machine learning community, since many algorithms are
solely designed for binary problems. It works by defining
the response in the j th problem as
Y ( j) =
{ 1, if Y = j ,
0, else
and running j times the entire procedure including feature
preselection, binary LogitBoost and stopping parameter
estimation on the data (x1, y( j)1 ), . . . , (xn, y
( j)
n ). This
yields estimates P̂[Y ( j) = 1|X ] for j ∈ {0, . . . , J − 1},
which can be converted into probability estimates for Y =
j via normalization,
P̂[Y = j |X ] = P̂
[
Y ( j) = 1|X]∑J
k=1 P̂
[
Y (k) = 1|X] .
This expression can be plugged into the Bayes classifier of
Equation (2) and it is easy to see that this yields
C(X) = argmax j∈{0,...,J−1}P̂
[
Y ( j) = 1|X
]
as our final classifier in multiclass problems. More sophis-
ticated and computationally more expensive approaches
for reducing multiclass to binary problems also exist, see
Hastie and Tibshirani (1998) or Allwein et al. (2000) for a
thorough discussion.
The one-against-all approach allows for different pres-
elected features, different chosen variables for the deci-
sion trees in the LogitBoost algorithm, and for different
model complexity via different stopping parameters for
every class discrimination. This adaption seems to be very
important with gene expression data. We observed, that the
multiclass LogitBoost of Friedman et al. (2000), which
treats the multiclass problem more simultaneously, per-
formed much worse in our study. In the NCI dataset, com-
prising J = 8 different tumor types, it yielded an error
rate of 36.1%, whereas with the one-against-all method,
the error-rate was only 22.9%. For the Lymphoma dataset
with J = 3 response classes, the one-against-all approach
is also superior with 1.61% versus 8.06%.
3 RESULTS
3.1 Real data
We explored the performance of our classification tech-
nique on six publicly available datasets.
Leukemia
This dataset contains gene expression levels of n =
72 patients either suffering from acute lymphoblastic
leukemia (ALL, 47 cases) or acute myeloid leukemia
(AML, 25 cases) and was obtained from Affymetrix
oligonucleotide microarrays. More information can be
found in Golub et al. (1999); the raw data are available
at http://www-genome.wi.mit.edu/cancer/. Following the
protocol in Dudoit et al. (2002), we preprocess them
by thresholding, filtering, a logarithmic transformation
and standardization, so that the data finally comprise the
expression values of p = 3571 genes.
Colon
In this dataset, expression levels of 40 tumor and 22
normal colon tissues for 6500 human genes are measured
using the Affymetrix technology. A selection of 2000
genes with highest minimal intensity across the samples
has been made by Alon et al. (1999), and these data
are publicly available at http://microarray.princeton.edu/
oncology/. As for the leukemia dataset, we process
these data further by carrying out a base 10 logarithmic
transformation and standardizing each tissue sample to
zero mean and unit variance across the genes.
Estrogen and Nodal
These datasets were first presented in recent papers of
West et al. (2001) and Spang et al. (2001). Their common
expression matrix monitors 7129 genes in 49 breast tumor
samples. The data are available at http://mgm.duke.edu/
genome/dna micro/work/ and were obtained by applying
the Affymetrix gene chip technology. We thresholded the
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raw data with a floor of 100 and a ceiling of 16 000
and then applied a base 10 logarithmic transformation.
Finally, each experiment was standardized to zero mean
and unit variance across the genes. Two different response
variables are available: The first one describes the status of
the estrogen receptor (ER). 25 samples are ER+, whereas
the remaining 24 samples are ER−. The second response
variable describes the lymph nodal (LN) status, which is
an indicator for the metastatic spread of the tumor, a very
important risk factor for disease outcome. Also here, 25
samples are positive (LN+) and 24 samples are negative
(LN−).
Lymphoma
This dataset is publicly available at http://llmpp.nih.gov/
lymphoma/data/figure1 and contains gene expression lev-
els of the J = 3 most prevalent adult lymphoid malignan-
cies: 42 samples of diffuse large B-cell lymphoma, 9 ob-
servations of follicular lymphoma and 11 cases of chronic
lymphocytic leukemia. The total sample size is n = 62,
and the expression of p = 4026 well-measured genes,
preferentially expressed in lymphoid cells or with known
immunological or oncological importance is documented.
More information on these data can be found in Alizadeh
et al. (2000). We imputed missing values and standardized
the data as described in Dudoit et al. (2002).
NCI
This dataset comprises gene expression levels of p =
5244 genes for n = 61 human tumor cell lines from cDNA
microarrays, which can be divided in J = 8 classes: 7
breast, 5 central nervous system, 7 colon, 6 leukemia, 8
melanoma, 9 non-small cell lung carcinoma, 6 ovarian
and 9 renal tumors. A more detailed description of the
data can be found on the website http://genome-www.
stanford.edu/nci60 and in Ross et al. (2000). We work
with preprocessed data as described in Dudoit et al.
(2002).
3.1.1 Empirical study We performed leave-one-out
cross validation to explore the classification potential
of our method. This means that we set aside the i th
observation and carry out feature selection, stopping
parameter estimation and classifier fitting by considering
only the remaining (n − 1) data points. We then predict
Ŷi , the class label of the i th observation and repeat this
process for all observations in the training sample. Each
observation is held out and predicted exactly once. We
determine the test set error using symmetrically equal
misclassification costs
Error = 1
n
n∑
i=1
1[Yi =Ŷi ].
Table 1 reports test set errors with different gene subset
size from feature selection for several classifiers. Logit-
Boost is reported with the optimal stopping time, yield-
ing the minimal cross-validated error across the boosting
iterations. This stopping time is not known in real life
problems and results in an over-optimistic misclassifica-
tion rate. Thus, also the error after a fixed number of 100
iterations as well as the error using our stopping parameter
estimate from Equation (3) are given. A close competitor
to LogitBoost is the discrete AdaBoost algorithm of Fre-
und and Schapire (1996). We report its error rate after 100
iterations and observe that its accuracy is inferior to Log-
itBoost in 19 cases, equal in 11 cases and superior in 12
cases. LogitBoost thus seems to have an edge over Ad-
aBoost, but this is far from being significant. To illustrate
the benefit of boosting, we also ran the (optimally tuned)
CART algorithm (Breiman et al., 1984) to produce sin-
gle classification trees. Boosting uses them as weak learn-
ers and leads to massive improvements in all except the
estrogen and nodal datasets. As a benchmark method we
applied the 1-nearest-neighbor classifier (Fix and Hodges,
1951) with simultaneous classification in multiclass prob-
lems, using all the genes from the one-against-all approach
in conjunction with boosting. This simple rule is known to
perform reasonably well on gene expression data in con-
nection with precedent feature selection. For the smaller
gene subsets, it is better than boosting for the leukemia
and lymphoma data, at about the same level for the colon
and NCI data and worse than boosting for the estrogen and
nodal data. With larger gene subsets, if many noise vari-
ables are present, its accuracy often deteriorates severely.
It is known that repeated random splitting of the data
into training and larger test sets may yield more accurate
estimates of the test set error than leave one out cross
validation, but the former has the disadvantage of being
difficult to reproduce. In our setting, the error rates
from random splitting (data not shown) were often at a
somewhat higher level, but the relationship between the
classifiers remained unchanged.
The choice of the stopping parameter for boosting is
not very critical in all six datasets. Our classifier did not
overfit much and Figure 1 shows that the error-rates are
at, or close to the minimal error rate for many boosting
iterations. We conjecture that stopping after a large, but
arbitrary number of 100 iterations is a reasonable strategy
in the context of gene expression data. Our data-driven
approach for estimating the stopping parameters by cross
validation on the training data does not improve and
most often yields slightly worse results, probably due to
additional random variation.
3.1.2 ROC curves In our evaluation, we determined the
test set error using symmetrically equal misclassification
costs. In a clinical setting, one often prefers to punish
misclassifications asymmetrically, since false negative
errors, i.e. classifying a tumorous tissue as normal can be
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Table 1. Test set error rates based on leave one out cross validation for leukemia, colon, estrogen, nodal, lymphoma and NCI data with gene subsets from
feature selection ranging between 10 to all genes for several classifiers. LogitBoost error rates are reported with optimal stopping (minimum cross-validated
error across iterations), after a fixed number of 100 iterations as well as with the estimated stopping parameter. The cross validation with estimated stopping
parameters for the lymphoma and NCI data with all genes was not feasible
Leukemia 10 25 50 75 100 200 3571
LogitBoost, optimal 4.17% 2.78% 4.17% 2.78% 2.78% 2.78% 2.78%
LogitBoost, estimated 6.94% 5.56% 5.56% 4.17% 4.17% 5.56% 5.56%
LogitBoost, 100 iterations 5.56% 2.78% 4.17% 2.78% 2.78% 2.78% 2.78%
AdaBoost, 100 iterations 4.17% 4.17% 4.17% 4.17% 4.17% 2.78% 4.17%
1-nearest-neighbor 4.17% 1.39% 4.17% 5.56% 4.17% 2.78% 1.39%
Classification tree 22.22% 22.22% 22.22% 22.22% 22.22% 22.22% 23.61%
Colon 10 25 50 75 100 200 2000
LogitBoost, optimal 14.52% 16.13% 16.13% 16.13% 16.13% 14.52% 12.90%
LogitBoost, estimated 22.58% 19.35% 22.58% 20.97% 22.58% 19.35% 19.35%
LogitBoost, 100 iterations 14.52% 22.58% 22.58% 19.35% 17.74% 16.13% 16.13%
AdaBoost, 100 iterations 16.13% 24.19% 24.19% 17.74% 20.97% 17.74% 17.74%
1-nearest-neighbor 17.74% 14.52% 14.52% 20.97% 19.35% 17.74% 25.81%
Classification tree 19.35% 22.58% 29.03% 32.26% 27.42% 14.52% 16.13%
Estrogen 10 25 50 75 100 200 7129
LogitBoost, optimal 4.08% 4.08% 2.04% 2.04% 2.04% 4.08% 2.04%
LogitBoost, estimated 6.12% 6.12% 6.12% 6.12% 6.12% 6.12% 6.12%
LogitBoost, 100 iterations 8.16% 6.12% 6.12% 4.08% 4.08% 8.16% 6.12%
AdaBoost, 100 iterations 8.16% 8.16% 2.04% 2.04% 6.12% 4.08% 4.08%
1-nearest-neighbor 4.08% 8.16% 18.37% 12.24% 14.29% 14.29% 16.33%
Classification tree 4.08% 4.08% 4.08% 4.08% 4.08% 4.08% 4.08%
Nodal 10 25 50 75 100 200 7129
LogitBoost, optimal 16.33% 18.37% 22.45% 22.45% 22.45% 18.37% 20.41%
LogitBoost, estimated 22.45% 30.61% 30.61% 34.69% 28.57% 26.53% 24.49%
LogitBoost, 100 iterations 18.37% 20.41% 26.53% 42.86% 42.86% 18.37% 22.45%
AdaBoost, 100 iterations 18.37% 16.33% 28.57% 40.82% 36.73% 22.45% 28.57%
1-nearest-neighbor 18.37% 30.61% 30.61% 42.86% 36.73% 36.73% 48.98%
Classification tree 22.45% 20.41% 20.41% 20.41% 20.41% 20.41% 20.41%
Lymphoma 10 25 50 75 100 200 4026
LogitBoost, optimal 1.61% 3.23% 1.61% 1.61% 1.61% 3.23% 8.06%
LogitBoost, estimated 3.23% 3.23% 3.23% 1.61% 3.23% 3.23% -%
LogitBoost, 100 iterations 1.61% 3.23% 1.61% 1.61% 1.61% 3.23% 8.06%
AdaBoost, 100 iterations 4.84% 3.23% 1.61% 1.61% 1.61% 1.61% 3.23%
Nearest neighbor 1.61% 0.00% 0.00% 0.00% 0.00% 1.61% 1.61%
Classification tree 22.58% 22.58% 22.58% 22.58% 22.58% 22.58% 25.81%
NCI 10 25 50 75 100 200 5244
LogitBoost, optimal 32.79% 31.15% 27.87% 22.95% 26.23% 24.59% 31.15%
LogitBoost, estimated 36.07% 44.26% 36.07% 39.34% 44.26% 47.54% -%
LogitBoost, 100 iterations 37.70% 44.26% 34.43% 29.51% 26.23% 24.59% 36.07%
AdaBoost, 100 iterations 50.82% 37.70% 34.43% 29.51% 32.79% 29.51% 36.07%
Nearest neighbor 36.07% 29.51% 27.87% 24.59% 22.95% 22.95% 27.87%
Classification tree 70.49% 68.85% 65.57% 65.57% 60.66% 62.30% 62.30%
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Fig. 1. Test set error curves for leukemia, colon and NCI data. The
number of genes was chosen such that the performance was optimal:
75 for leukemia and NCI data, and 2000 for the colon data. The error
curves for estrogen, nodal and lymphoma data look similar and are
not displayed for reasons of clarity.
fatal, whereas false positive errors, i.e. predicting a normal
tissue as a tumor may be less serious since in this case
additional tests will be carried out.
ROC curves illustrate how accurate classifiers are un-
der asymmetric losses, by plotting the tradeoff between
false positives and false negatives. Each point on the two-
dimensional ROC curve corresponds to a particular prob-
ability β ∈ [0, 1] that was used as a threshold for pos-
itive (tumorous) classification. The (x, y) coordinates of
each point are then the fractions of negative and positive
samples that are classified as positive with this particular
threshold β. In the ideal case, the ROC curve goes through
(0, 1), the upper left corner of the plot.
Figure 2 shows the ROC curves for LogitBoost after 100
iterations, AdaBoost after 100 iterations and classification
trees applied to the colon data with p˜ = 2000 predictor
variables. The class membership probabilities for each
sample were determined by leave one out cross validation.
We can see that both boosting classifiers yield a similar
curve which comes closer to the ideal ROC curve than the
one from classification trees. Note that this is a case where
the test set errors under equal misclassification losses are
very similar. However for this example, Boosting has an
advantage for small negative rates.
3.1.3 Validation of the results The leukemia dataset
has been considered by many authors. On the original test
set comprising 34 observations, LogitBoost assigns the
correct label to 33 of the 34 patients. This can be directly
compared to the study in Golub et al. (1999), where 29
observations were classified correctly by their weighted
voting scheme. Furey et al. (2000), working with support
vector machines, report results ranging between 30 to
32 correct classifications. Ben-Dor et al. (2000) applied
AdaBoost and carried out cross validation. After 10 000
boosting iterations, they obtained 2.78% misclassified and
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Fig. 2. ROC curves for LogitBoost, AdaBoost and classification
trees applied on colon data without feature preselection. On the
x-axis is the fraction of negative examples classified as positives
(tumorous), the y-axis show the fraction of positive examples
classified as positives. Each point on the curves represents the
fractions achieved with a particular probability β ∈ [0, 1] as
threshold for positive classification. The probabilities for class
membership were estimated by leave-one-out cross validation.
1.39% unclassified instances without feature preselection,
and 1.39% either mis- or unclassified instances with
several gene subsets.
The colon dataset has been cross validated by Ben-Dor
et al. (2000) with various classifiers, with and without
precedent feature selection. AdaBoost performed com-
parably bad and the best result they report are 17.74%
of misclassified, plus another 9.68% of unclassified
instances. Our best results here are in the range between
12.90% and 14.52% wrongly classified observations.
We gain evidence that LogitBoost can be superior over
AdaBoost in some cases. The best support vector machine
of Furey et al. (2000) misclassified only 6 tissue samples
in the full cross validation cycle, being equivalent to
an error-rate of 9.68%, whereas our error-rate of 12.9%
corresponds to 8 misclassifications.
The NCI dataset has been extensively analyzed by
Dudoit et al. (2002). They tried several classification
methods including AdaBoost on a precedently reduced
feature space. Also in their study, AdaBoosting was not
among the best classifiers with a median error of about
48% in 150 random divisions in training and test set. Our
method with reduction to binary problems and LogitBoost
shows a considerable improvement to an error of only
22.9%, but a part of this reduction could be caused by
the two different setups, i.e. random divisions versus cross
validation for estimating the test set error.
For the estrogen and nodal datasets, we obtain better
predictions than West et al. (2001) with their Bayesian
approach, even without omitting the most difficult cases
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as they do. A validation of the results for the lymphoma
dataset in comparison to other studies is not possible.
Since our classifier does well with respect to the bench-
marks, we expect that it yields competitive results here
too.
3.2 Simulation
Due to the scarcity of samples in real datasets, relevant
differences between classification methods may be diffi-
cult to detect. We consider here simulated gene expression
data: by generating large test sets, the performance of our
modified LogitBoost classifier can be much more accu-
rately compared against the benchmark classifiers and as-
sessing significant differences becomes possible. We start
by producing gene expression profiles from a multivariate
normal distribution, X ∼ Np(0, ), where the covariance
structure  is from the colon dataset. This reflects the real
situation with microarray data, yielding gene expression
profiles with p = 2000 genes. We continue by assigning
one out of two response classes to the simulated expres-
sion profiles according to Y | X = x ∼ Bernoulli(p(x)),
where the conditional probabilities are from the model
log
p(x)
1 − p(x) =
10∑
j=1
β j x¯ (C j )
(
1 + γ j x¯ (C j )
) (
1 + δ j x¯ (C j )
)
The x¯ (C j ) = ∑g∈C j x (g)/|C j | are mean values across
random gene clusters C j ⊆ {1, . . . , p} of uniformly
random size between 1 and 10 genes, the expected
number of relevant genes is thus 10 · 5.5 = 55. The
model coefficients β j , γ j and δ j were randomly drawn
from normal distributions with zero mean and standard
deviation σ = 2, 1 and 1/2, respectively. This leads
to a complex non-additive decision boundary, where
LogitBoost with stumps, which fits an additive model, is
not in favor of the benchmark classifiers†.
The training sample size was chosen to be n = 200 and
we considered the performance of the classifiers on single
but large test sets comprising 1000 new observations.
The process was independently repeated 20 times, which
enables to explore whether LogitBoost yields significantly
better test set error-rates than the benchmark classifiers
by performing paired Wilcoxon signed rank tests for the
hypothesis of equal misclassifications against the two-
sided alternative. The test always points towards better
accuracy of LogitBoost, results are given in Table 2.
Not only when the LogitBoost algorithm was optimally
stopped, but also after a fixed number of 150 iterations
(which was found to be a reasonable ad-hoc choice for
this problem) it significantly outperformed the benchmark
† LogitBoost with larger trees would allow to pick up nonadditive decision
boundaries.
Table 2. Percentual improvement and p-values of LogitBoost (stopped
optimally and after a fixed number of 150 iterations) against the generic
1-nearest-neighbor method and classification trees in 20 independent
realizations from our simulation model. The p-values are from paired two-
sided Wilcoxon signed rank tests for equal test set error and are always in
favor of LogitBoost
1-Nearest-Neighbor
LogitBoost, optimal 12.37%, p = 1.7 · 10−4
LogitBoost, 150 iterations 7.54%, p = 1.4 · 10−3
Classification Tree
LogitBoost, optimal 10.21%, p = 1.1 · 10−3
LogitBoost, 150 iterations 5.27%, p = 1.7 · 10−2
methods. This confirms our findings from real data that
our classifier is more accurate than the benchmarks.
4 CONCLUSIONS
We propose modifications and extensions of boosting clas-
sifiers for microarray gene expression data from several
tissue or cancer types. We applied precedent feature selec-
tion and used the more robust LogitBoost combined with
an alternative approach for binary problems. The results
on six real and a simulated datasets indicate that these
modifications are successful and make boosting a com-
petitive player for predicting expression data. Our feature
preselection generally improved the predictive power of
a classifier. Moreover, we observed slightly better perfor-
mance of LogitBoost over AdaBoost, and our whole pro-
cedure (feature selection plus LogitBoost) compares fa-
vorably with previously published results using AdaBoost.
Finally, we propose to reduce multiclass problems to mul-
tiple binary problems which are solved separately. This
was found to have a great potential for more accurate re-
sults on gene expression data, where the choice of predic-
tor variables is crucial.
Our LogitBoost classifier is very suitable for application
in a clinical setting. In comparison to other methods, it
yields good results, is easy to implement and does not
require sophisticated tuning and model or kernel selection
as with neural networks or support vector machines.
Unlike several other classifiers, it directly provides class
membership probabilities. They are essential to quantify
the uncertainty of a class label assignment and allow
decisions under unequal misclassification costs which are
often encountered in practice.
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